Now Live The BioInsights Podcast Modernizing cell therapy manufacturing to reduce vein-to-vein times

Listen now

GPB Scientific Announces $25.5 Million Financing from Vensana Capital and Amgen Ventures

GPB Scientific, Inc., a developer of breakthrough technologies for therapeutic cell production and bioprocessing, today announced a $25.5 million funding commitment. The financing is led by Vensana Capital alongside strategic investor Amgen Ventures with ongoing participation by existing investors…

Read the full article.